Gaps in Manufacturer Support Leave Healthcare Retailers Vulnerable in Rx-to-OTC Switches, Withdrawals, Recalls, and Other Unplanned Events; Improved P
According to findings from a recent IRI/National Association of Chain Drug Stores (NACDS) survey of healthcare executives among the country’s leading retailers, current manufacturing planning processes and support levels for Rx-to-OTC (over-the-counter) switches and drug recalls and withdrawals are sub-par, leaving retailers vulnerable to lost sales and unhappy customers.
Register now and read the rest of this article.
Registered users have access to all online content including SymphonyIRI Group publications, white papers, podcasts, and more.
Click here to register
today and get immediate access.
Already registered?
Log In Now
|